Haema Blood Donation Service

What Haema Blood Donation Service does

Haema is a German private-sector blood and plasma collection company headquartered in Leipzig, operating the largest private donation network in Germany with 40 centers across multiple federal states. The company collects whole blood and source plasma from voluntary donors through these centers and channels collected plasma into its parent company Grifols, a global plasma-derived pharmaceuticals manufacturer. Haema operates as Haema GmbH and is functionally the German collection arm of Grifols, with no independent public listing or external funding.

The company's underlying technology stack centers on a centralized medical laboratory and processing facility in Leipzig, which performs immunohematology, molecular biology, and serology testing and processes up to 15,000 laboratory tubes per day, delivering up to 65,000 test results daily. Apheresis machines are used at the donation centers for plasma collection, and a dedicated medical logistics network transports donations and laboratory samples daily. The operation is governed by German and EU regulatory frameworks, including GMP, GLP, § 14 AMWHV, and national transfusion medicine guidelines. SAP SuccessFactors is deployed for talent acquisition, and an internal Haema Weiterbildungs-Academy provides workforce training.

Haema's commercial model is dual-channel: a direct-to-consumer donation acquisition channel, with donors recruited through the Haema brand and center network, and a back-end channel that feeds plasma into Grifols' pharmaceutical value chain. Donor compensation is structured as expense allowances rather than disclosed service fees, and pricing is not publicly available. The company employs approximately 1,300 staff across medical, laboratory, logistics, and corporate functions, with active hiring ongoing across all four major operational areas.

Name

Haema Blood Donation Service

Legal name

Haema GmbH

Website

https://karriere.haema.de

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Haema is Germany's largest private blood and plasma donation service, operating 40 donation centers and a centralized Leipzig laboratory that processes collected plasma into pharmaceutical inputs for its parent company Grifols.

Ownership category

akta.pro rank

Product category

Blood and Plasma Donation Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Plasma-Derived & Blood Products Distributors (HLAIAJAJ), Plasma-Derived Therapy Cold Chain & Specialty Logistics (HLAIAHAL)

Keywords

• Blood donation services
• Plasma collection
• Blood product processing
• Medical laboratory testing
• Plasma-derived pharmaceuticals

Headquarters

HQ city

Leipzig

HQ country

Germany

HQ region

Europe

Offices27 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Blood and Plasma Collection Services: Collects blood and plasma donations from voluntary donors at 40 donation centers across Germany. The collected plasma and blood products are processed into life-saving medicines.
2. Plasma-Derived Pharmaceutical Products: Through partnership with Grifols, plasma is processed into innovative plasma-based medicines for treating patients worldwide

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Haema operates Germany's largest private network of blood and plasma donation services, running 40 donation centers that collect whole blood and plasma from voluntary donors. Collected donations are processed and tested at the company's high-capacity laboratory in Leipzig (up to 15,000 tubes and 65,000 test results daily) and supplied to parent company Grifols for manufacturing into plasma-derived medicines distributed globally.

Product overview

Haema operates as Germany's largest private blood and plasma donation service, offering a network of 40 donation centers where donors can give blood and plasma. The company provides end-to-end services including donor collection, laboratory testing of up to 65,000 test results per day, and processing donations into plasma-based medicines. Haema partners with Grifols, a global healthcare company, to develop innovative plasma medicines. The company's operations span donation collection, medical logistics, laboratory analysis, and distribution, supported by an internal training academy (Haema Weiterbildungs-Academy) for employee development.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood and Plasma Donation Collection Services Collection of blood and plasma donations from healthy voluntary donors at 40 donation centers across Germany, including medical examinations, venipuncture procedures, and donor monitoring during the donation process.
• Blood and Plasma Processing Processing of collected blood and plasma donations into usable blood components for medical treatment at the Leipzig production facility.
• Laboratory Testing Services High-volume medical laboratory testing in Leipzig performing quality assurance on blood and plasma products, processing up to 15,000 laboratory tubes and delivering up to 65,000 test results per day, including immunohematology, molecular biology, and serology testing.
• Medical Logistics Services Temperature-controlled transportation of blood donations, plasma samples, and laboratory specimens from 40 donation centers to the Leipzig laboratory and production facilities by dedicated courier drivers.

Quantifiable outcome

• 40 donation centers across Germany serving communities nationwide
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• GrifolscoreStrategic or Co-development PartnerHaema is part of Grifols, a globally leading healthcare company. The partnership focuses on developing innovative plasma-based medicines. Haema collects plasma which is processed by Grifols into life-saving pharmaceutical products for patients worldwide. The combined mission is to improve health and well-being of people globally.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Regional players

• Sanquin: Dutch national blood and plasma collection organization operating plasmapheresis centers and a fractionation facility. Comparable as a European non-profit/private hybrid plasma collector with cross-border relevance to Haema's operating model.
• NHS Blood and Transplant: UK national blood and plasma service operating a nationwide network of donation centers. Comparable as a large-scale, geographically distributed blood/plasma collection organization with similar operational complexity to Haema.

Broad incumbents

• Biotest (Grifols subsidiary): German-based plasma-derived therapy company now owned by Grifols. Highly comparable as a Grifols group entity in plasma fractionation, providing direct adjacency context to Haema's downstream value chain.
• Grifols: Haema's parent company and a global leader in plasma-derived medicines. Grifols fractionates Haema's collected plasma into immunoglobulins, albumin, and clotting factors, making it the most direct commercial counterpart in Haema's value chain.
• Kedrion Biopharma: Italy-headquartered plasma fractionator that sources plasma through its own collection centers and partnerships in Europe and the U.S. A relevant comparable on the supply-and-process side of the European plasma market in which Haema operates.
• Octapharma: Global plasma fractionator that also operates its own plasma collection centers in Europe and the U.S. A relevant peer given its vertically integrated model of plasma collection plus fractionation, paralleling Haema's role within Grifols.

Direct peers

• DRK Blutspendedienst: German Red Cross blood donation service — the dominant non-profit blood and plasma collector in Germany. Most direct domestic competitor for donor mindshare, hospital supply contracts, and plasma volumes within Haema's home market.
• BioLife Plasma Services: Plasma collection network owned by Takeda, operating donor centers across the U.S. and Europe. Directly comparable to Haema as a dedicated plasma-collection subsidiary of a fractionator, with similar apheresis-based operations and donor compensation economics.
• CSL Plasma: One of the world's largest plasma collection networks, owned by CSL Behring. Operates donation centers globally and competes with Haema for plasma donors; highly comparable in business model (apheresis collection, donor compensation, fractionation feed into a parent manufacturer).

Others

• Haemonetics: Supplier of apheresis plasma collection devices and blood management software. Comparable as an enabling technology and equipment vendor whose plasmapheresis machines are used by networks like Haema.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/haema-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haema Blood Donation Service